<DOC>
	<DOCNO>NCT01935908</DOCNO>
	<brief_summary>The purpose study determine feasibility prospectively enrol randomize patient aneurysmal subarachnoid hemorrhage ( aSAH ) receive levetiracetam receive levetiracetam , document in-hospital follow-up clinical variable .</brief_summary>
	<brief_title>Seizure Prophylaxis With Levetiracetam Aneurysmal Subarachnoid Hemorrhage - Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>≥ 18 year age ≤ 75 year age Newly diagnose aneurysmal subarachnoid hemorrhage One antiepileptic medication take preadmission medication Seizure occurrence field emergency department , anytime consent could obtain Inability obtain informed consent patient , patient 's appropriate surrogate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Subarachnoid Hemorrhage</keyword>
	<keyword>Seizures</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Levetiracetam</keyword>
</DOC>